Therapy plans for therapeutic apheresis in Epic HealthLink

IF 1.4 4区 医学 Q4 HEMATOLOGY Journal of Clinical Apheresis Pub Date : 2023-06-27 DOI:10.1002/jca.22072
Vansh S. Jain, Huihua Li, Kristin P. Lee, William Nicholas Rose
{"title":"Therapy plans for therapeutic apheresis in Epic HealthLink","authors":"Vansh S. Jain,&nbsp;Huihua Li,&nbsp;Kristin P. Lee,&nbsp;William Nicholas Rose","doi":"10.1002/jca.22072","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>A common required duty of pathology resident physicians while rotating on transfusion medicine is the medical oversight of the therapeutic apheresis service. A task often performed on this clinical medicine service is formulating and writing orders for therapeutic apheresis procedures. The EpicCare tool called the therapy plan provides unique advantages over a standard electronic order set for therapeutic apheresis.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>Transfusion medicine physicians, apheresis nurses, pharmacists, and information technology professionals collaborated to create therapy plans for three therapeutic apheresis procedures: plasmapheresis, red cell exchange, and photopheresis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Therapy plans were implemented and have been well-received for several years. Over a six-year time period, a total of 613 therapy plans were created and signed. We speculate that this implementation may have increased both physician efficiency and patient safety.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This article reports our experience using therapy plans in EpicCare in order to raise awareness of this tool and to serve as an encouragement for wider adoption.</p>\n </section>\n </div>","PeriodicalId":15390,"journal":{"name":"Journal of Clinical Apheresis","volume":"38 5","pages":"611-614"},"PeriodicalIF":1.4000,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jca.22072","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Apheresis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jca.22072","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

A common required duty of pathology resident physicians while rotating on transfusion medicine is the medical oversight of the therapeutic apheresis service. A task often performed on this clinical medicine service is formulating and writing orders for therapeutic apheresis procedures. The EpicCare tool called the therapy plan provides unique advantages over a standard electronic order set for therapeutic apheresis.

Materials and Methods

Transfusion medicine physicians, apheresis nurses, pharmacists, and information technology professionals collaborated to create therapy plans for three therapeutic apheresis procedures: plasmapheresis, red cell exchange, and photopheresis.

Results

Therapy plans were implemented and have been well-received for several years. Over a six-year time period, a total of 613 therapy plans were created and signed. We speculate that this implementation may have increased both physician efficiency and patient safety.

Conclusion

This article reports our experience using therapy plans in EpicCare in order to raise awareness of this tool and to serve as an encouragement for wider adoption.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epic HealthLink中治疗性单采的治疗计划。
背景:病理住院医师在轮流从事输血医学工作时,一项常见的职责是对治疗性单采服务进行医疗监督。这项临床医学服务经常执行的任务是制定和编写单采治疗程序的订单。与治疗单采的标准电子订单集相比,名为治疗计划的EpicCare工具提供了独特的优势。材料和方法:输血医生、单采护士、药剂师和信息技术专业人员合作制定了三种单采治疗程序的治疗计划:血浆置换、红细胞交换和光疗法。结果:治疗计划得到了实施,并在几年内受到了好评。在六年的时间里,共制定并签署了613项治疗计划。我们推测,这种实施方式可能提高了医生的效率和患者的安全性。结论:本文报告了我们在EpicCare中使用治疗计划的经验,以提高对该工具的认识,并鼓励更广泛的采用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
13.30%
发文量
70
审稿时长
>12 weeks
期刊介绍: The Journal of Clinical Apheresis publishes articles dealing with all aspects of hemapheresis. Articles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytapheresis, therapeutic absorption, blood component collection and transfusion, donor recruitment and safety, administration of hemapheresis centers, and innovative applications of hemapheresis technology. Experimental studies, clinical trials, case reports, and concise reviews will be welcomed.
期刊最新文献
Enhancing Apheresis Knowledge: An Educational Intervention for Non-Apheresis Medical Providers What's in a Name: Your PLEX or PEX Is Our TPE Clotted Apheresis Hematopoietic Stem Cell Product I-JAMM (II)-Therapeutic Apheresis Practices in Preconditioning of ABO-Incompatible Kidney and Liver Transplants in India. An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1